 Kenneth Tyler
Concepts (771)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Reoviridae Infections | 40 | 2019 | 52 | 8.290 |
Why?
| | West Nile Fever | 22 | 2023 | 50 | 7.420 |
Why?
| | Encephalitis, Viral | 23 | 2021 | 39 | 6.130 |
Why?
| | West Nile virus | 17 | 2023 | 38 | 6.050 |
Why?
| | Enterovirus D, Human | 13 | 2023 | 72 | 5.710 |
Why?
| | Enterovirus Infections | 13 | 2023 | 160 | 4.990 |
Why?
| | Central Nervous System Viral Diseases | 17 | 2023 | 63 | 4.880 |
Why?
| | Reoviridae | 26 | 2019 | 35 | 4.530 |
Why?
| | Myelitis | 20 | 2022 | 88 | 4.520 |
Why?
| | Leukoencephalopathy, Progressive Multifocal | 15 | 2019 | 38 | 4.290 |
Why?
| | Mammalian orthoreovirus 3 | 30 | 2019 | 34 | 3.900 |
Why?
| | Nervous System Diseases | 15 | 2020 | 253 | 3.700 |
Why?
| | Apoptosis | 44 | 2021 | 2377 | 3.700 |
Why?
| | Brain | 37 | 2023 | 2370 | 3.470 |
Why?
| | Antiviral Agents | 19 | 2023 | 651 | 3.050 |
Why?
| | Neuromuscular Diseases | 9 | 2022 | 90 | 2.310 |
Why?
| | Central Nervous System Infections | 7 | 2022 | 36 | 2.250 |
Why?
| | Neurology | 12 | 2017 | 85 | 2.230 |
Why?
| | Zika Virus Infection | 5 | 2017 | 85 | 2.170 |
Why?
| | Encephalitis | 8 | 2022 | 127 | 1.880 |
Why?
| | Neurons | 21 | 2022 | 1298 | 1.870 |
Why?
| | Acyclovir | 9 | 2020 | 100 | 1.860 |
Why?
| | Paralysis | 9 | 2023 | 67 | 1.810 |
Why?
| | Encephalitis, Herpes Simplex | 8 | 2020 | 20 | 1.760 |
Why?
| | Host-Pathogen Interactions | 5 | 2021 | 296 | 1.720 |
Why?
| | Mice | 74 | 2023 | 15052 | 1.720 |
Why?
| | Animals | 107 | 2023 | 32102 | 1.660 |
Why?
| | Microglia | 7 | 2023 | 203 | 1.640 |
Why?
| | Multiple Sclerosis | 5 | 2022 | 380 | 1.480 |
Why?
| | Simplexvirus | 13 | 2020 | 82 | 1.460 |
Why?
| | Meningoencephalitis | 6 | 2021 | 24 | 1.450 |
Why?
| | Herpes Simplex | 7 | 2021 | 88 | 1.350 |
Why?
| | Zika Virus | 4 | 2017 | 61 | 1.340 |
Why?
| | Polymerase Chain Reaction | 17 | 2018 | 1000 | 1.330 |
Why?
| | Spinal Cord | 8 | 2021 | 351 | 1.280 |
Why?
| | Communicable Diseases, Emerging | 4 | 2016 | 28 | 1.280 |
Why?
| | Central Nervous System Diseases | 5 | 2023 | 61 | 1.260 |
Why?
| | Cell Death | 4 | 2022 | 326 | 1.240 |
Why?
| | Humans | 157 | 2023 | 115587 | 1.230 |
Why?
| | Herpesviridae Infections | 6 | 2013 | 138 | 1.180 |
Why?
| | High-Throughput Nucleotide Sequencing | 2 | 2022 | 443 | 1.180 |
Why?
| | Viral Load | 6 | 2023 | 405 | 1.160 |
Why?
| | Meningitis, Viral | 8 | 2020 | 21 | 1.120 |
Why?
| | Virus Replication | 19 | 2021 | 396 | 1.080 |
Why?
| | Central Nervous System | 9 | 2017 | 239 | 1.070 |
Why?
| | Interferon-beta | 4 | 2019 | 79 | 1.060 |
Why?
| | Disease Outbreaks | 6 | 2022 | 308 | 1.040 |
Why?
| | JC Virus | 8 | 2015 | 23 | 1.030 |
Why?
| | Disease Models, Animal | 13 | 2023 | 3580 | 1.030 |
Why?
| | Meningitis | 4 | 2023 | 74 | 1.010 |
Why?
| | Arbovirus Infections | 3 | 2019 | 17 | 1.000 |
Why?
| | Pneumonia, Viral | 2 | 2020 | 344 | 0.990 |
Why?
| | Epstein-Barr Virus Infections | 2 | 2022 | 71 | 0.990 |
Why?
| | Coronavirus Infections | 2 | 2020 | 336 | 0.990 |
Why?
| | Motor Neurons | 3 | 2019 | 213 | 0.950 |
Why?
| | Monkeypox virus | 3 | 2023 | 12 | 0.950 |
Why?
| | Cytokines | 9 | 2022 | 1853 | 0.940 |
Why?
| | Herpesvirus 1, Human | 3 | 2021 | 78 | 0.930 |
Why?
| | Signal Transduction | 17 | 2019 | 4541 | 0.930 |
Why?
| | Creutzfeldt-Jakob Syndrome | 5 | 2007 | 14 | 0.910 |
Why?
| | Orthoreovirus, Mammalian | 4 | 2011 | 5 | 0.910 |
Why?
| | Virion | 3 | 2022 | 74 | 0.900 |
Why?
| | Granulocyte-Macrophage Colony-Stimulating Factor | 2 | 2023 | 140 | 0.890 |
Why?
| | Caspase 3 | 7 | 2023 | 237 | 0.880 |
Why?
| | Guillain-Barre Syndrome | 3 | 2020 | 21 | 0.880 |
Why?
| | Dog Diseases | 2 | 2021 | 41 | 0.870 |
Why?
| | Sexual and Gender Minorities | 2 | 2022 | 138 | 0.870 |
Why?
| | Capsid Proteins | 8 | 2004 | 69 | 0.850 |
Why?
| | Natalizumab | 4 | 2019 | 46 | 0.850 |
Why?
| | Minocycline | 2 | 2017 | 26 | 0.840 |
Why?
| | Astrocytes | 5 | 2019 | 163 | 0.820 |
Why?
| | Virus Diseases | 7 | 2009 | 200 | 0.810 |
Why?
| | Spine | 2 | 2017 | 141 | 0.800 |
Why?
| | Fluoxetine | 3 | 2018 | 46 | 0.800 |
Why?
| | Immunity, Innate | 5 | 2021 | 731 | 0.790 |
Why?
| | Meningitis, Bacterial | 4 | 2010 | 49 | 0.770 |
Why?
| | Caspase Inhibitors | 5 | 2011 | 78 | 0.750 |
Why?
| | Exosomes | 1 | 2022 | 92 | 0.740 |
Why?
| | Critical Care | 2 | 2017 | 477 | 0.730 |
Why?
| | Betacoronavirus | 2 | 2020 | 254 | 0.710 |
Why?
| | Encephalitis, California | 2 | 2019 | 11 | 0.700 |
Why?
| | Encephalitis, Tick-Borne | 2 | 2019 | 8 | 0.700 |
Why?
| | Hashimoto Disease | 1 | 2019 | 9 | 0.690 |
Why?
| | N-Acetylneuraminic Acid | 1 | 2019 | 9 | 0.680 |
Why?
| | Axonal Transport | 1 | 2019 | 21 | 0.680 |
Why?
| | Immunosuppressive Agents | 3 | 2015 | 666 | 0.680 |
Why?
| | Cell Line | 18 | 2022 | 2651 | 0.680 |
Why?
| | Zoonoses | 2 | 2009 | 21 | 0.670 |
Why?
| | Periodicals as Topic | 1 | 2021 | 183 | 0.660 |
Why?
| | Immune System | 2 | 2020 | 173 | 0.660 |
Why?
| | Encephalitis, Japanese | 1 | 2018 | 2 | 0.640 |
Why?
| | Orthoreovirus | 5 | 1998 | 6 | 0.640 |
Why?
| | JNK Mitogen-Activated Protein Kinases | 5 | 2009 | 146 | 0.620 |
Why?
| | Prion Diseases | 3 | 2008 | 10 | 0.590 |
Why?
| | Herpes Zoster | 2 | 2015 | 333 | 0.580 |
Why?
| | Neurosyphilis | 2 | 2013 | 3 | 0.580 |
Why?
| | Plasma Exchange | 1 | 2017 | 12 | 0.570 |
Why?
| | Hepatitis E | 1 | 2017 | 2 | 0.570 |
Why?
| | Hepatitis E virus | 1 | 2017 | 2 | 0.570 |
Why?
| | Enzyme Inhibitors | 3 | 2011 | 757 | 0.570 |
Why?
| | NF-kappa B | 7 | 2010 | 639 | 0.570 |
Why?
| | Antibodies, Monoclonal | 11 | 2009 | 1265 | 0.570 |
Why?
| | Virology | 1 | 2016 | 19 | 0.560 |
Why?
| | Herpesvirus 3, Human | 3 | 2015 | 381 | 0.560 |
Why?
| | bcl-2 Homologous Antagonist-Killer Protein | 1 | 2016 | 14 | 0.550 |
Why?
| | Macrophage Activation | 1 | 2017 | 165 | 0.550 |
Why?
| | Viruses | 6 | 2009 | 94 | 0.550 |
Why?
| | Myocarditis | 5 | 2009 | 94 | 0.550 |
Why?
| | Alzheimer Disease | 1 | 2021 | 438 | 0.540 |
Why?
| | Prions | 3 | 2008 | 33 | 0.540 |
Why?
| | Caspases | 9 | 2013 | 245 | 0.530 |
Why?
| | Immunocompromised Host | 5 | 2009 | 197 | 0.510 |
Why?
| | History, 20th Century | 10 | 2016 | 273 | 0.510 |
Why?
| | Thrombocytopenia | 1 | 2017 | 175 | 0.510 |
Why?
| | Gene Expression Regulation | 6 | 2010 | 2353 | 0.500 |
Why?
| | Toll-Like Receptor 3 | 2 | 2014 | 26 | 0.500 |
Why?
| | Chikungunya Fever | 1 | 2016 | 61 | 0.500 |
Why?
| | Cerebrospinal Fluid | 7 | 2005 | 88 | 0.490 |
Why?
| | Anti-Inflammatory Agents | 3 | 2017 | 448 | 0.490 |
Why?
| | Propylene Glycols | 1 | 2015 | 26 | 0.490 |
Why?
| | Valine | 1 | 2015 | 74 | 0.490 |
Why?
| | Glial Fibrillary Acidic Protein | 5 | 2021 | 79 | 0.490 |
Why?
| | Antibodies, Viral | 7 | 2019 | 527 | 0.490 |
Why?
| | Medication Reconciliation | 1 | 2015 | 25 | 0.490 |
Why?
| | Sphingosine | 1 | 2015 | 32 | 0.490 |
Why?
| | Calpain | 4 | 2008 | 53 | 0.470 |
Why?
| | Encephalitis Viruses, Japanese | 1 | 2014 | 1 | 0.470 |
Why?
| | Leukoencephalitis, Acute Hemorrhagic | 2 | 2020 | 3 | 0.470 |
Why?
| | Nervous System | 2 | 2007 | 63 | 0.470 |
Why?
| | Encephalitis, St. Louis | 1 | 2014 | 2 | 0.470 |
Why?
| | Encephalitis Virus, St. Louis | 1 | 2014 | 3 | 0.470 |
Why?
| | Drug Discovery | 1 | 2015 | 124 | 0.470 |
Why?
| | Capsid | 5 | 1997 | 76 | 0.460 |
Why?
| | PrPSc Proteins | 2 | 2004 | 5 | 0.460 |
Why?
| | Receptors, Death Domain | 1 | 2013 | 3 | 0.460 |
Why?
| | Viral Proteins | 8 | 2000 | 286 | 0.460 |
Why?
| | Interferon Type I | 2 | 2013 | 129 | 0.460 |
Why?
| | Peripheral Nervous System | 1 | 2013 | 18 | 0.450 |
Why?
| | Male | 48 | 2023 | 55949 | 0.450 |
Why?
| | TNF-Related Apoptosis-Inducing Ligand | 5 | 2007 | 40 | 0.450 |
Why?
| | Heart | 3 | 2011 | 608 | 0.440 |
Why?
| | Penicillins | 1 | 2013 | 52 | 0.440 |
Why?
| | Neuroglia | 3 | 2012 | 150 | 0.440 |
Why?
| | Epidemics | 1 | 2014 | 70 | 0.440 |
Why?
| | Carrier Proteins | 6 | 2013 | 701 | 0.430 |
Why?
| | Viral Nonstructural Proteins | 2 | 2005 | 56 | 0.430 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 2016 | 449 | 0.420 |
Why?
| | Phagocytosis | 1 | 2014 | 355 | 0.420 |
Why?
| | Acute Disease | 6 | 2018 | 914 | 0.410 |
Why?
| | Receptor, Interferon alpha-beta | 2 | 2012 | 22 | 0.410 |
Why?
| | Enterovirus | 3 | 2023 | 72 | 0.410 |
Why?
| | DNA, Viral | 8 | 2003 | 351 | 0.410 |
Why?
| | STAT1 Transcription Factor | 3 | 2012 | 64 | 0.400 |
Why?
| | United States | 13 | 2023 | 12295 | 0.390 |
Why?
| | Antibodies, Monoclonal, Murine-Derived | 2 | 2011 | 80 | 0.390 |
Why?
| | Animals, Newborn | 9 | 2021 | 780 | 0.390 |
Why?
| | Brain Diseases | 3 | 2020 | 127 | 0.390 |
Why?
| | Gene Expression Profiling | 3 | 2014 | 1536 | 0.380 |
Why?
| | bcl-2-Associated X Protein | 1 | 2011 | 46 | 0.380 |
Why?
| | Female | 41 | 2021 | 59913 | 0.370 |
Why?
| | Caspase 8 | 5 | 2013 | 43 | 0.370 |
Why?
| | Immunoglobulins, Intravenous | 3 | 2019 | 123 | 0.370 |
Why?
| | Macrophages | 1 | 2017 | 1284 | 0.370 |
Why?
| | fas Receptor | 2 | 2009 | 93 | 0.360 |
Why?
| | Chemokines | 2 | 2022 | 214 | 0.360 |
Why?
| | History, 19th Century | 10 | 2010 | 56 | 0.360 |
Why?
| | Genes, Viral | 9 | 1998 | 89 | 0.360 |
Why?
| | Cysteine Proteinase Inhibitors | 3 | 2001 | 45 | 0.360 |
Why?
| | Virus Internalization | 2 | 2022 | 41 | 0.360 |
Why?
| | Neuroprotective Agents | 1 | 2011 | 105 | 0.350 |
Why?
| | Tumor Necrosis Factor-alpha | 4 | 2003 | 1137 | 0.350 |
Why?
| | Antibodies, Neutralizing | 3 | 2022 | 222 | 0.350 |
Why?
| | Up-Regulation | 5 | 2016 | 820 | 0.350 |
Why?
| | CASP8 and FADD-Like Apoptosis Regulating Protein | 2 | 2007 | 20 | 0.350 |
Why?
| | Flavivirus Infections | 2 | 2019 | 9 | 0.350 |
Why?
| | Immunomodulation | 1 | 2010 | 85 | 0.340 |
Why?
| | Cerebellum | 3 | 2012 | 200 | 0.340 |
Why?
| | Membrane Glycoproteins | 5 | 2004 | 431 | 0.340 |
Why?
| | Enzyme Activation | 3 | 2010 | 793 | 0.340 |
Why?
| | Cell Cycle | 2 | 2002 | 546 | 0.320 |
Why?
| | Cells, Cultured | 12 | 2013 | 3914 | 0.320 |
Why?
| | Multiple Sclerosis, Relapsing-Remitting | 2 | 2009 | 69 | 0.310 |
Why?
| | Bone Morphogenetic Proteins | 1 | 2009 | 133 | 0.310 |
Why?
| | HeLa Cells | 7 | 2018 | 567 | 0.310 |
Why?
| | Discitis | 1 | 2008 | 2 | 0.310 |
Why?
| | Motor Neuron Disease | 1 | 2008 | 16 | 0.300 |
Why?
| | Bone Diseases, Infectious | 1 | 2008 | 8 | 0.300 |
Why?
| | Spinal Cord Diseases | 1 | 2008 | 39 | 0.300 |
Why?
| | Bell Palsy | 1 | 2007 | 6 | 0.300 |
Why?
| | Caspase 9 | 4 | 2013 | 48 | 0.300 |
Why?
| | Back Pain | 1 | 2008 | 44 | 0.290 |
Why?
| | Janus Kinases | 1 | 2007 | 13 | 0.290 |
Why?
| | Prednisolone | 1 | 2007 | 77 | 0.290 |
Why?
| | Rituximab | 3 | 2021 | 149 | 0.290 |
Why?
| | Apoptosis Regulatory Proteins | 7 | 2005 | 174 | 0.290 |
Why?
| | Cytomegalovirus | 2 | 2004 | 146 | 0.290 |
Why?
| | Wasting Disease, Chronic | 1 | 2007 | 18 | 0.280 |
Why?
| | Kuru | 2 | 2004 | 2 | 0.280 |
Why?
| | Adult | 26 | 2022 | 30718 | 0.280 |
Why?
| | Transforming Growth Factor beta | 1 | 2009 | 446 | 0.270 |
Why?
| | Health Services Needs and Demand | 1 | 2008 | 249 | 0.270 |
Why?
| | Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2007 | 58 | 0.270 |
Why?
| | Mitochondrial Proteins | 2 | 2005 | 219 | 0.270 |
Why?
| | Homosexuality, Male | 3 | 2022 | 170 | 0.260 |
Why?
| | Feces | 1 | 2008 | 372 | 0.260 |
Why?
| | Child, Preschool | 9 | 2022 | 9133 | 0.260 |
Why?
| | Dogs | 4 | 2021 | 341 | 0.260 |
Why?
| | Cytochromes c | 2 | 2005 | 62 | 0.260 |
Why?
| | Integrin alpha4 | 1 | 2005 | 6 | 0.260 |
Why?
| | Mice, Knockout | 7 | 2012 | 2604 | 0.260 |
Why?
| | Magnetic Resonance Imaging | 10 | 2023 | 3069 | 0.260 |
Why?
| | Viral Tropism | 2 | 2018 | 24 | 0.250 |
Why?
| | Child | 15 | 2022 | 18488 | 0.250 |
Why?
| | Herpesvirus 4, Human | 2 | 2022 | 123 | 0.250 |
Why?
| | Encephalomyelitis, Eastern Equine | 2 | 2019 | 6 | 0.250 |
Why?
| | RNA, Viral | 5 | 2004 | 565 | 0.250 |
Why?
| | Opportunistic Infections | 1 | 2005 | 44 | 0.250 |
Why?
| | Health Surveys | 1 | 2007 | 446 | 0.250 |
Why?
| | Nitric Oxide Synthase | 1 | 2005 | 213 | 0.240 |
Why?
| | Scrapie | 1 | 2004 | 2 | 0.240 |
Why?
| | Intracellular Signaling Peptides and Proteins | 4 | 2013 | 388 | 0.240 |
Why?
| | Acquired Immunodeficiency Syndrome | 2 | 2003 | 221 | 0.240 |
Why?
| | History, 21st Century | 3 | 2016 | 162 | 0.240 |
Why?
| | Immunologic Factors | 2 | 2021 | 220 | 0.240 |
Why?
| | Recombinant Proteins | 3 | 2023 | 1243 | 0.240 |
Why?
| | Oligodendroglia | 2 | 2003 | 149 | 0.240 |
Why?
| | Cell Nucleus | 2 | 2004 | 553 | 0.230 |
Why?
| | Mitochondria | 5 | 2016 | 750 | 0.230 |
Why?
| | Active Transport, Cell Nucleus | 1 | 2004 | 111 | 0.230 |
Why?
| | Adjuvants, Immunologic | 1 | 2005 | 206 | 0.230 |
Why?
| | Blotting, Western | 5 | 2010 | 1153 | 0.230 |
Why?
| | Middle Aged | 23 | 2019 | 26999 | 0.230 |
Why?
| | Hand, Foot and Mouth Disease | 1 | 2023 | 3 | 0.220 |
Why?
| | Medical Tourism | 1 | 2023 | 9 | 0.220 |
Why?
| | Treatment Outcome | 8 | 2019 | 9159 | 0.220 |
Why?
| | Age of Onset | 1 | 2005 | 450 | 0.220 |
Why?
| | Encephalomyelitis, Acute Disseminated | 2 | 2020 | 13 | 0.220 |
Why?
| | Roseolovirus Infections | 1 | 2003 | 6 | 0.220 |
Why?
| | Arthropod Vectors | 2 | 2016 | 7 | 0.220 |
Why?
| | Neutralization Tests | 4 | 2017 | 63 | 0.220 |
Why?
| | Herpesvirus 6, Human | 1 | 2003 | 13 | 0.220 |
Why?
| | Reassortant Viruses | 3 | 2005 | 7 | 0.220 |
Why?
| | Antigens, Viral | 4 | 2009 | 177 | 0.220 |
Why?
| | Nitric Oxide Synthase Type II | 2 | 2017 | 160 | 0.220 |
Why?
| | Immunization, Passive | 3 | 1993 | 80 | 0.220 |
Why?
| | Immunohistochemistry | 3 | 2017 | 1642 | 0.220 |
Why?
| | Glucocorticoids | 1 | 2007 | 552 | 0.220 |
Why?
| | Disease Progression | 7 | 2010 | 2418 | 0.220 |
Why?
| | Flavivirus | 2 | 2019 | 16 | 0.220 |
Why?
| | BH3 Interacting Domain Death Agonist Protein | 3 | 2009 | 10 | 0.210 |
Why?
| | Encephalomyelitis | 1 | 2022 | 9 | 0.210 |
Why?
| | Arthritis, Rheumatoid | 1 | 2011 | 1002 | 0.210 |
Why?
| | Olfactory Mucosa | 1 | 2003 | 60 | 0.210 |
Why?
| | HIV Infections | 2 | 2013 | 2473 | 0.210 |
Why?
| | Antibodies, Monoclonal, Humanized | 4 | 2017 | 667 | 0.210 |
Why?
| | Poliomyelitis | 1 | 2022 | 27 | 0.210 |
Why?
| | Muscular Dystrophy, Duchenne | 1 | 2003 | 81 | 0.210 |
Why?
| | Organ Culture Techniques | 2 | 2014 | 143 | 0.210 |
Why?
| | Survival Analysis | 3 | 2018 | 1219 | 0.210 |
Why?
| | Virulence | 6 | 2005 | 231 | 0.210 |
Why?
| | Cytomegalovirus Infections | 1 | 2004 | 182 | 0.210 |
Why?
| | Densitometry | 1 | 2022 | 29 | 0.200 |
Why?
| | Anti-Bacterial Agents | 5 | 2022 | 1484 | 0.200 |
Why?
| | Sequence Analysis, DNA | 4 | 2017 | 732 | 0.200 |
Why?
| | Poliovirus | 1 | 2022 | 77 | 0.200 |
Why?
| | Ovarian Neoplasms | 1 | 2007 | 407 | 0.200 |
Why?
| | Organ Transplantation | 1 | 2004 | 161 | 0.200 |
Why?
| | Pandemics | 2 | 2020 | 1334 | 0.200 |
Why?
| | Exanthema | 1 | 2022 | 77 | 0.200 |
Why?
| | DNA Repair | 1 | 2003 | 190 | 0.200 |
Why?
| | Peptides | 1 | 2007 | 864 | 0.200 |
Why?
| | Mycobacterium abscessus | 1 | 2023 | 98 | 0.200 |
Why?
| | Nervous System Malformations | 1 | 2022 | 34 | 0.190 |
Why?
| | Stroke | 2 | 2020 | 1016 | 0.190 |
Why?
| | CDC2 Protein Kinase | 1 | 2001 | 25 | 0.190 |
Why?
| | Enterovirus A, Human | 1 | 2021 | 12 | 0.190 |
Why?
| | Interferons | 2 | 2014 | 152 | 0.190 |
Why?
| | Dipeptides | 1 | 2001 | 49 | 0.180 |
Why?
| | G2 Phase | 1 | 2000 | 31 | 0.180 |
Why?
| | Manuscripts, Medical as Topic | 1 | 2000 | 4 | 0.180 |
Why?
| | DNA-Directed DNA Polymerase | 2 | 1998 | 44 | 0.180 |
Why?
| | Herpes Zoster Ophthalmicus | 1 | 2020 | 5 | 0.180 |
Why?
| | Pigmentation Disorders | 1 | 2020 | 7 | 0.180 |
Why?
| | Disseminated Intravascular Coagulation | 1 | 2020 | 30 | 0.180 |
Why?
| | Anti-Infective Agents | 2 | 2022 | 225 | 0.180 |
Why?
| | Encephalitis Virus, California | 2 | 2019 | 6 | 0.180 |
Why?
| | Sinus Thrombosis, Intracranial | 1 | 2020 | 22 | 0.180 |
Why?
| | Inflammation | 3 | 2020 | 2499 | 0.180 |
Why?
| | Ophthalmoplegia | 1 | 1999 | 8 | 0.180 |
Why?
| | Facial Paralysis | 1 | 1999 | 17 | 0.170 |
Why?
| | Receptors, Tumor Necrosis Factor | 1 | 2000 | 139 | 0.170 |
Why?
| | Immunoglobulin G | 3 | 2019 | 781 | 0.170 |
Why?
| | Thrombophilia | 1 | 2020 | 66 | 0.170 |
Why?
| | Molecular Sequence Data | 4 | 2011 | 2790 | 0.170 |
Why?
| | Central Nervous System Bacterial Infections | 1 | 1999 | 5 | 0.170 |
Why?
| | Craniofacial Abnormalities | 1 | 2020 | 59 | 0.170 |
Why?
| | Intracranial Hemorrhages | 1 | 2020 | 76 | 0.170 |
Why?
| | Bunyaviridae Infections | 1 | 2019 | 6 | 0.170 |
Why?
| | Olfaction Disorders | 1 | 2020 | 48 | 0.170 |
Why?
| | Time Factors | 9 | 2008 | 6165 | 0.170 |
Why?
| | Pons | 1 | 1999 | 30 | 0.170 |
Why?
| | Nerve Degeneration | 2 | 2011 | 40 | 0.170 |
Why?
| | Genes, pol | 2 | 1998 | 7 | 0.170 |
Why?
| | Adaptor Proteins, Signal Transducing | 2 | 2012 | 374 | 0.170 |
Why?
| | Mitosis | 1 | 2000 | 164 | 0.170 |
Why?
| | Myelitis, Transverse | 1 | 2019 | 3 | 0.170 |
Why?
| | Gliosis | 1 | 2019 | 30 | 0.170 |
Why?
| | North America | 2 | 2019 | 261 | 0.170 |
Why?
| | Writing | 1 | 2000 | 85 | 0.160 |
Why?
| | Myelin-Oligodendrocyte Glycoprotein | 1 | 2019 | 43 | 0.160 |
Why?
| | MAP Kinase Kinase Kinase 1 | 3 | 2004 | 14 | 0.160 |
Why?
| | Mental Disorders | 1 | 2007 | 902 | 0.160 |
Why?
| | rho-Associated Kinases | 1 | 2019 | 81 | 0.160 |
Why?
| | Encephalitis Virus, Japanese | 1 | 2018 | 1 | 0.160 |
Why?
| | Blood-Brain Barrier | 1 | 2019 | 106 | 0.160 |
Why?
| | Receptors, Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2018 | 12 | 0.160 |
Why?
| | Abnormalities, Multiple | 1 | 2020 | 176 | 0.160 |
Why?
| | Mycobacterium Infections, Nontuberculous | 1 | 2023 | 337 | 0.160 |
Why?
| | Choledochal Cyst | 1 | 1998 | 17 | 0.160 |
Why?
| | Proto-Oncogene Proteins c-bcl-2 | 3 | 2007 | 214 | 0.160 |
Why?
| | Cell Adhesion Molecules | 1 | 2019 | 168 | 0.160 |
Why?
| | Organ Specificity | 2 | 2013 | 273 | 0.150 |
Why?
| | Interferon-alpha | 2 | 2011 | 186 | 0.150 |
Why?
| | Cytopathogenic Effect, Viral | 1 | 1998 | 16 | 0.150 |
Why?
| | Neurogenesis | 1 | 2019 | 102 | 0.150 |
Why?
| | Skin | 1 | 2022 | 662 | 0.150 |
Why?
| | Tissue Culture Techniques | 2 | 2021 | 67 | 0.150 |
Why?
| | Glioblastoma | 1 | 2000 | 253 | 0.150 |
Why?
| | Hybridomas | 2 | 1995 | 230 | 0.150 |
Why?
| | Neuromyelitis Optica | 1 | 2019 | 114 | 0.150 |
Why?
| | Brazil | 1 | 2017 | 93 | 0.150 |
Why?
| | Autoantibodies | 3 | 2021 | 1360 | 0.140 |
Why?
| | Dexamethasone | 2 | 2017 | 316 | 0.140 |
Why?
| | Induced Pluripotent Stem Cells | 1 | 2019 | 183 | 0.140 |
Why?
| | Memory Disorders | 2 | 2016 | 155 | 0.140 |
Why?
| | Cranial Nerve Diseases | 1 | 2017 | 42 | 0.140 |
Why?
| | Movement Disorders | 1 | 2017 | 46 | 0.140 |
Why?
| | Transcription Factors | 1 | 2005 | 1528 | 0.140 |
Why?
| | Brain Ischemia | 1 | 2020 | 298 | 0.140 |
Why?
| | Microfilament Proteins | 1 | 2017 | 126 | 0.140 |
Why?
| | Microscopy, Electron, Transmission | 1 | 2017 | 138 | 0.140 |
Why?
| | Muscular Diseases | 1 | 2017 | 104 | 0.140 |
Why?
| | Protein Binding | 3 | 2016 | 1917 | 0.140 |
Why?
| | Ticks | 1 | 2016 | 12 | 0.130 |
Why?
| | Calcium-Binding Proteins | 1 | 2017 | 203 | 0.130 |
Why?
| | Encephalitis Viruses, Tick-Borne | 1 | 2016 | 7 | 0.130 |
Why?
| | Colorado | 5 | 2022 | 4113 | 0.130 |
Why?
| | Encephalopathy, Bovine Spongiform | 1 | 1995 | 2 | 0.130 |
Why?
| | Culicidae | 1 | 2016 | 29 | 0.130 |
Why?
| | Presynaptic Terminals | 1 | 2016 | 55 | 0.130 |
Why?
| | Interferon-gamma | 1 | 2019 | 726 | 0.130 |
Why?
| | Microcephaly | 1 | 2016 | 52 | 0.130 |
Why?
| | Protein Interaction Mapping | 1 | 2016 | 102 | 0.130 |
Why?
| | Biliary Atresia | 1 | 1998 | 185 | 0.130 |
Why?
| | Cell Proliferation | 1 | 2023 | 2194 | 0.130 |
Why?
| | DNA | 3 | 2017 | 1356 | 0.130 |
Why?
| | Arcuate Nucleus of Hypothalamus | 1 | 1995 | 13 | 0.130 |
Why?
| | Agricultural Workers' Diseases | 1 | 1995 | 23 | 0.130 |
Why?
| | Nerve Tissue Proteins | 1 | 2019 | 535 | 0.130 |
Why?
| | Myocardium | 3 | 2005 | 926 | 0.130 |
Why?
| | Spleen | 4 | 2011 | 492 | 0.130 |
Why?
| | Muscle Hypotonia | 1 | 2015 | 31 | 0.130 |
Why?
| | Brain Stem | 1 | 1995 | 102 | 0.120 |
Why?
| | Chikungunya virus | 1 | 2016 | 61 | 0.120 |
Why?
| | Cell Count | 2 | 2005 | 305 | 0.120 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 3 | 2011 | 795 | 0.120 |
Why?
| | Nerve Fibers | 1 | 1995 | 87 | 0.120 |
Why?
| | Cricetinae | 3 | 2012 | 260 | 0.120 |
Why?
| | Medulla Oblongata | 1 | 1994 | 33 | 0.120 |
Why?
| | Cerebral Infarction | 1 | 1994 | 39 | 0.120 |
Why?
| | Aged | 9 | 2019 | 19251 | 0.120 |
Why?
| | Fingolimod Hydrochloride | 1 | 2015 | 30 | 0.120 |
Why?
| | Demyelinating Diseases | 1 | 1995 | 75 | 0.120 |
Why?
| | Virus Cultivation | 1 | 2014 | 25 | 0.120 |
Why?
| | West Nile Virus Vaccines | 1 | 2014 | 1 | 0.120 |
Why?
| | Endopeptidases | 1 | 1994 | 72 | 0.120 |
Why?
| | Receptors, Interleukin-17 | 1 | 2014 | 5 | 0.120 |
Why?
| | Neuronal Plasticity | 1 | 2016 | 214 | 0.120 |
Why?
| | Facial Nerve | 2 | 2007 | 31 | 0.120 |
Why?
| | Epilepsy | 1 | 1998 | 290 | 0.120 |
Why?
| | Proto-Oncogene Proteins c-jun | 2 | 2005 | 47 | 0.120 |
Why?
| | rac GTP-Binding Proteins | 2 | 2012 | 34 | 0.120 |
Why?
| | Fibroblasts | 4 | 2007 | 839 | 0.120 |
Why?
| | Kidney | 2 | 2011 | 1207 | 0.120 |
Why?
| | Amino Acyl-tRNA Synthetases | 1 | 2014 | 28 | 0.120 |
Why?
| | Microarray Analysis | 1 | 2014 | 119 | 0.110 |
Why?
| | Practice Guidelines as Topic | 3 | 2007 | 1405 | 0.110 |
Why?
| | Pregnancy Complications, Infectious | 1 | 2017 | 289 | 0.110 |
Why?
| | Treponema pallidum | 1 | 2013 | 7 | 0.110 |
Why?
| | Neoplasm Recurrence, Local | 1 | 2019 | 863 | 0.110 |
Why?
| | Gene Expression Regulation, Viral | 2 | 2005 | 80 | 0.110 |
Why?
| | Bacterial Toxins | 2 | 2012 | 103 | 0.110 |
Why?
| | RNA-Binding Proteins | 1 | 1996 | 362 | 0.110 |
Why?
| | Tachycardia | 1 | 2013 | 49 | 0.110 |
Why?
| | Complement System Proteins | 1 | 2016 | 288 | 0.110 |
Why?
| | Biomarkers | 2 | 2017 | 3466 | 0.110 |
Why?
| | Propidium | 1 | 2013 | 4 | 0.110 |
Why?
| | Hydro-Lyases | 1 | 2013 | 4 | 0.110 |
Why?
| | Immunotherapy, Adoptive | 2 | 1993 | 194 | 0.110 |
Why?
| | Rats | 7 | 2012 | 5034 | 0.110 |
Why?
| | Cryoultramicrotomy | 1 | 2013 | 3 | 0.110 |
Why?
| | Myocytes, Cardiac | 2 | 2009 | 457 | 0.110 |
Why?
| | Buffers | 1 | 2013 | 54 | 0.110 |
Why?
| | Cerebrospinal Fluid Proteins | 2 | 2005 | 10 | 0.110 |
Why?
| | Leukocytosis | 2 | 2005 | 35 | 0.110 |
Why?
| | History, 18th Century | 2 | 2010 | 20 | 0.100 |
Why?
| | Phagosomes | 1 | 2012 | 40 | 0.100 |
Why?
| | B-Lymphocytes | 2 | 2009 | 773 | 0.100 |
Why?
| | Drug Design | 1 | 2013 | 156 | 0.100 |
Why?
| | Glutamic Acid | 1 | 2014 | 213 | 0.100 |
Why?
| | Etoposide | 2 | 2003 | 149 | 0.100 |
Why?
| | Cytoplasm | 1 | 2013 | 255 | 0.100 |
Why?
| | Genetic Techniques | 2 | 2011 | 57 | 0.100 |
Why?
| | STAT5 Transcription Factor | 1 | 2012 | 44 | 0.100 |
Why?
| | Fluorescent Antibody Technique | 1 | 2013 | 398 | 0.100 |
Why?
| | Fever | 1 | 2013 | 280 | 0.100 |
Why?
| | Myxovirus Resistance Proteins | 1 | 2011 | 8 | 0.100 |
Why?
| | Dose-Response Relationship, Drug | 3 | 2005 | 1870 | 0.100 |
Why?
| | Cerebral Cortex | 2 | 2005 | 386 | 0.100 |
Why?
| | Nitrendipine | 1 | 1991 | 13 | 0.100 |
Why?
| | T-Lymphocytes | 3 | 1998 | 1756 | 0.100 |
Why?
| | Cyclosporins | 1 | 1991 | 59 | 0.090 |
Why?
| | Infant | 5 | 2022 | 7979 | 0.090 |
Why?
| | Verapamil | 1 | 1991 | 32 | 0.090 |
Why?
| | Histocytochemistry | 1 | 2011 | 78 | 0.090 |
Why?
| | Fatal Outcome | 3 | 2009 | 286 | 0.090 |
Why?
| | GTP-Binding Proteins | 1 | 2011 | 142 | 0.090 |
Why?
| | Oligonucleotide Array Sequence Analysis | 2 | 2003 | 746 | 0.090 |
Why?
| | Caspases, Effector | 1 | 2010 | 2 | 0.090 |
Why?
| | Autophagy | 1 | 2012 | 236 | 0.090 |
Why?
| | Medical Illustration | 1 | 2010 | 9 | 0.090 |
Why?
| | History, 17th Century | 1 | 2010 | 16 | 0.090 |
Why?
| | Hippocampus | 2 | 2005 | 709 | 0.090 |
Why?
| | Glutamate Plasma Membrane Transport Proteins | 1 | 2009 | 5 | 0.090 |
Why?
| | Virus Physiological Phenomena | 1 | 2009 | 6 | 0.090 |
Why?
| | Interferon Regulatory Factors | 1 | 2010 | 29 | 0.090 |
Why?
| | Disease Vectors | 1 | 2009 | 11 | 0.090 |
Why?
| | Greenhouse Effect | 1 | 2009 | 6 | 0.090 |
Why?
| | Microscopy | 1 | 2011 | 125 | 0.090 |
Why?
| | Muscle, Skeletal | 2 | 2017 | 1447 | 0.090 |
Why?
| | RNA, Messenger | 2 | 2009 | 2574 | 0.080 |
Why?
| | Animals, Wild | 1 | 2009 | 44 | 0.080 |
Why?
| | United Kingdom | 2 | 2003 | 227 | 0.080 |
Why?
| | Bone Morphogenetic Protein Receptors, Type I | 1 | 2009 | 10 | 0.080 |
Why?
| | Microtubule-Associated Proteins | 2 | 2012 | 174 | 0.080 |
Why?
| | Smad1 Protein | 1 | 2009 | 18 | 0.080 |
Why?
| | Mutation | 4 | 2014 | 3364 | 0.080 |
Why?
| | Smad3 Protein | 1 | 2009 | 41 | 0.080 |
Why?
| | Lymphocytic Choriomeningitis | 1 | 2009 | 12 | 0.080 |
Why?
| | Kinetics | 3 | 2005 | 1569 | 0.080 |
Why?
| | DNA Primers | 2 | 2003 | 514 | 0.080 |
Why?
| | Virus Activation | 3 | 2003 | 78 | 0.080 |
Why?
| | Receptors, Virus | 2 | 2005 | 75 | 0.080 |
Why?
| | Bacterial Proteins | 2 | 2012 | 739 | 0.080 |
Why?
| | Reperfusion Injury | 1 | 1991 | 254 | 0.080 |
Why?
| | Nuclear Proteins | 1 | 2013 | 594 | 0.080 |
Why?
| | Epidural Space | 1 | 2008 | 6 | 0.080 |
Why?
| | Prognosis | 3 | 2019 | 3339 | 0.080 |
Why?
| | Myokymia | 1 | 2007 | 2 | 0.080 |
Why?
| | Schizophrenia, Paranoid | 1 | 2007 | 9 | 0.080 |
Why?
| | Adolescent | 6 | 2020 | 17889 | 0.080 |
Why?
| | Developing Countries | 1 | 2009 | 240 | 0.080 |
Why?
| | Poly(ADP-ribose) Polymerases | 1 | 2008 | 88 | 0.070 |
Why?
| | Retrospective Studies | 6 | 2022 | 12608 | 0.070 |
Why?
| | STAT2 Transcription Factor | 1 | 2007 | 3 | 0.070 |
Why?
| | Seizures | 2 | 2008 | 344 | 0.070 |
Why?
| | Cell Movement | 2 | 2003 | 867 | 0.070 |
Why?
| | Potassium Channels, Voltage-Gated | 1 | 2007 | 48 | 0.070 |
Why?
| | Intervertebral Disc | 1 | 2008 | 38 | 0.070 |
Why?
| | Phosphorylation | 2 | 2012 | 1571 | 0.070 |
Why?
| | Morbidity | 1 | 2008 | 278 | 0.070 |
Why?
| | Disease Reservoirs | 1 | 2007 | 19 | 0.070 |
Why?
| | Vero Cells | 3 | 2012 | 65 | 0.070 |
Why?
| | Herpesvirus Vaccines | 1 | 2007 | 4 | 0.070 |
Why?
| | Lung Transplantation | 1 | 2009 | 246 | 0.070 |
Why?
| | Survival Rate | 1 | 2011 | 1650 | 0.070 |
Why?
| | Herpesviridae | 1 | 2007 | 21 | 0.070 |
Why?
| | Global Health | 1 | 2009 | 290 | 0.070 |
Why?
| | Mice, Mutant Strains | 1 | 2007 | 271 | 0.070 |
Why?
| | Hemagglutinins, Viral | 1 | 1986 | 6 | 0.070 |
Why?
| | Risk | 1 | 2009 | 819 | 0.070 |
Why?
| | Hepatovirus | 1 | 1986 | 3 | 0.070 |
Why?
| | Disease Transmission, Infectious | 1 | 2007 | 57 | 0.070 |
Why?
| | Meningitis, Aseptic | 2 | 2003 | 15 | 0.070 |
Why?
| | Transfusion Reaction | 1 | 2007 | 66 | 0.070 |
Why?
| | Mice, Inbred Strains | 4 | 1993 | 399 | 0.070 |
Why?
| | Virus Latency | 1 | 2007 | 80 | 0.070 |
Why?
| | Risk Factors | 4 | 2009 | 8697 | 0.070 |
Why?
| | Cell Division | 2 | 2000 | 759 | 0.070 |
Why?
| | S-Nitroso-N-Acetylpenicillamine | 1 | 2005 | 4 | 0.070 |
Why?
| | Mice, Inbred C57BL | 4 | 2013 | 4773 | 0.070 |
Why?
| | Serologic Tests | 1 | 2005 | 51 | 0.070 |
Why?
| | Glutathione | 1 | 2007 | 303 | 0.070 |
Why?
| | NG-Nitroarginine Methyl Ester | 1 | 2005 | 38 | 0.070 |
Why?
| | Osmolar Concentration | 1 | 2005 | 178 | 0.060 |
Why?
| | Interferon beta-1a | 1 | 2005 | 12 | 0.060 |
Why?
| | Promoter Regions, Genetic | 1 | 2010 | 1122 | 0.060 |
Why?
| | Analgesics | 1 | 2007 | 157 | 0.060 |
Why?
| | Aged, 80 and over | 2 | 2007 | 6417 | 0.060 |
Why?
| | Orthoreovirus, Avian | 1 | 2005 | 1 | 0.060 |
Why?
| | rac1 GTP-Binding Protein | 1 | 2005 | 57 | 0.060 |
Why?
| | Administration, Oral | 2 | 2004 | 734 | 0.060 |
Why?
| | England | 2 | 2000 | 63 | 0.060 |
Why?
| | Predictive Value of Tests | 2 | 2009 | 1805 | 0.060 |
Why?
| | Saimiri | 1 | 2004 | 6 | 0.060 |
Why?
| | Neurophysiology | 1 | 1984 | 14 | 0.060 |
Why?
| | Drug Therapy, Combination | 1 | 2007 | 962 | 0.060 |
Why?
| | Digestive System | 1 | 2004 | 27 | 0.060 |
Why?
| | Nuclear Lamina | 1 | 2004 | 10 | 0.060 |
Why?
| | Nuclear Pore | 1 | 2004 | 14 | 0.060 |
Why?
| | Ultraviolet Rays | 2 | 1999 | 372 | 0.060 |
Why?
| | Pregnancy | 1 | 2016 | 5548 | 0.060 |
Why?
| | Nuclear Localization Signals | 1 | 2004 | 14 | 0.060 |
Why?
| | Serotyping | 1 | 2004 | 28 | 0.060 |
Why?
| | Pancreas Transplantation | 1 | 2004 | 64 | 0.060 |
Why?
| | Amino Acid Chloromethyl Ketones | 1 | 2004 | 22 | 0.060 |
Why?
| | Clinical Trials as Topic | 1 | 2009 | 941 | 0.060 |
Why?
| | Down-Regulation | 1 | 2007 | 601 | 0.060 |
Why?
| | Thalamus | 1 | 2005 | 78 | 0.060 |
Why?
| | Random Allocation | 1 | 2005 | 337 | 0.060 |
Why?
| | Retinal Ganglion Cells | 1 | 1985 | 92 | 0.060 |
Why?
| | Inflammation Mediators | 2 | 2021 | 479 | 0.060 |
Why?
| | Inclusion Bodies, Viral | 1 | 2003 | 2 | 0.060 |
Why?
| | Glycoproteins | 1 | 2005 | 309 | 0.060 |
Why?
| | AIDS-Related Opportunistic Infections | 2 | 2009 | 117 | 0.060 |
Why?
| | Vinculin | 1 | 2003 | 10 | 0.060 |
Why?
| | Follow-Up Studies | 3 | 2017 | 4440 | 0.060 |
Why?
| | Enterovirus B, Human | 1 | 2023 | 24 | 0.060 |
Why?
| | Reflex, Stretch | 1 | 1983 | 9 | 0.060 |
Why?
| | Diagnostic Techniques, Ophthalmological | 1 | 2003 | 36 | 0.060 |
Why?
| | Skin Diseases, Vesiculobullous | 1 | 2003 | 17 | 0.050 |
Why?
| | Liver | 1 | 2011 | 1690 | 0.050 |
Why?
| | Herpesvirus 2, Human | 1 | 2003 | 27 | 0.050 |
Why?
| | Hepatolenticular Degeneration | 1 | 1983 | 16 | 0.050 |
Why?
| | Chorea | 1 | 1983 | 11 | 0.050 |
Why?
| | Infusions, Intravenous | 1 | 2004 | 374 | 0.050 |
Why?
| | Adrenal Cortex Hormones | 1 | 2007 | 509 | 0.050 |
Why?
| | Isoxazoles | 1 | 2023 | 56 | 0.050 |
Why?
| | Diagnosis, Differential | 3 | 2017 | 1357 | 0.050 |
Why?
| | Mice, Inbred BALB C | 2 | 1998 | 1168 | 0.050 |
Why?
| | District of Columbia | 1 | 2022 | 25 | 0.050 |
Why?
| | Luciferases | 1 | 2003 | 140 | 0.050 |
Why?
| | Muscular Dystrophies | 1 | 1983 | 36 | 0.050 |
Why?
| | Tumor Virus Infections | 1 | 2002 | 41 | 0.050 |
Why?
| | Cryoelectron Microscopy | 1 | 2023 | 144 | 0.050 |
Why?
| | Retina | 1 | 1985 | 267 | 0.050 |
Why?
| | Genes, Reporter | 1 | 2003 | 257 | 0.050 |
Why?
| | Tissue Distribution | 1 | 2003 | 324 | 0.050 |
Why?
| | Ribavirin | 1 | 2003 | 89 | 0.050 |
Why?
| | AIDS Dementia Complex | 1 | 2002 | 50 | 0.050 |
Why?
| | Models, Biological | 2 | 2003 | 1646 | 0.050 |
Why?
| | Receptors, Cell Surface | 1 | 2004 | 356 | 0.050 |
Why?
| | Multivariate Analysis | 1 | 2005 | 1440 | 0.050 |
Why?
| | Transfection | 1 | 2004 | 866 | 0.050 |
Why?
| | Proto-Oncogene Proteins | 1 | 2005 | 609 | 0.050 |
Why?
| | I-kappa B Proteins | 1 | 2002 | 78 | 0.050 |
Why?
| | Electromyography | 2 | 2017 | 324 | 0.050 |
Why?
| | Body Fluids | 1 | 2001 | 58 | 0.050 |
Why?
| | Endoplasmic Reticulum | 1 | 2003 | 235 | 0.050 |
Why?
| | Patients | 1 | 2002 | 164 | 0.050 |
Why?
| | Radiography | 1 | 2004 | 826 | 0.050 |
Why?
| | Pain | 1 | 2007 | 712 | 0.050 |
Why?
| | Phenotype | 1 | 2009 | 2829 | 0.050 |
Why?
| | Amino Acid Sequence | 2 | 2004 | 2000 | 0.050 |
Why?
| | Ligands | 1 | 2003 | 569 | 0.050 |
Why?
| | Case-Control Studies | 2 | 2017 | 3022 | 0.050 |
Why?
| | Creatine Kinase | 1 | 2001 | 72 | 0.050 |
Why?
| | Fas-Associated Death Domain Protein | 1 | 2000 | 8 | 0.050 |
Why?
| | Haplorhini | 1 | 2000 | 60 | 0.050 |
Why?
| | Receptors, TNF-Related Apoptosis-Inducing Ligand | 1 | 2000 | 26 | 0.050 |
Why?
| | Species Specificity | 2 | 1995 | 552 | 0.040 |
Why?
| | Rats, Sprague-Dawley | 4 | 2009 | 2262 | 0.040 |
Why?
| | Nitric Oxide | 1 | 2005 | 832 | 0.040 |
Why?
| | False Positive Reactions | 1 | 2000 | 109 | 0.040 |
Why?
| | Knee Joint | 1 | 1983 | 325 | 0.040 |
Why?
| | Cell Line, Tumor | 1 | 2007 | 2751 | 0.040 |
Why?
| | Population Surveillance | 1 | 2003 | 395 | 0.040 |
Why?
| | Administration, Intravenous | 1 | 2020 | 126 | 0.040 |
Why?
| | Recurrence | 3 | 1995 | 952 | 0.040 |
Why?
| | Bunyamwera virus | 1 | 2019 | 3 | 0.040 |
Why?
| | Multiplex Polymerase Chain Reaction | 1 | 2020 | 45 | 0.040 |
Why?
| | Membrane Proteins | 1 | 2005 | 1024 | 0.040 |
Why?
| | Molecular Diagnostic Techniques | 1 | 2020 | 91 | 0.040 |
Why?
| | Gerstmann-Straussler-Scheinker Disease | 1 | 1999 | 1 | 0.040 |
Why?
| | Creosote | 1 | 1999 | 2 | 0.040 |
Why?
| | Antidiarrheals | 1 | 1999 | 15 | 0.040 |
Why?
| | Muscle Weakness | 1 | 1999 | 80 | 0.040 |
Why?
| | Cross-Sectional Studies | 1 | 2009 | 4435 | 0.040 |
Why?
| | Hematopoietic Stem Cell Transplantation | 1 | 2004 | 519 | 0.040 |
Why?
| | Stem Cells | 1 | 2023 | 546 | 0.040 |
Why?
| | Jejunum | 1 | 1999 | 24 | 0.040 |
Why?
| | Mitogen-Activated Protein Kinases | 1 | 2000 | 277 | 0.040 |
Why?
| | Virus Attachment | 1 | 2018 | 11 | 0.040 |
Why?
| | Acrylates | 1 | 1999 | 47 | 0.040 |
Why?
| | A549 Cells | 1 | 2018 | 51 | 0.040 |
Why?
| | Age Factors | 1 | 2005 | 2907 | 0.040 |
Why?
| | Kidney Transplantation | 1 | 2004 | 558 | 0.040 |
Why?
| | Epitopes | 2 | 1991 | 438 | 0.040 |
Why?
| | Antimicrobial Stewardship | 1 | 2020 | 93 | 0.040 |
Why?
| | Neural Pathways | 1 | 1999 | 260 | 0.040 |
Why?
| | Arboviruses | 1 | 2017 | 10 | 0.040 |
Why?
| | Vasculitis | 1 | 1998 | 71 | 0.040 |
Why?
| | In Vitro Techniques | 2 | 1999 | 1044 | 0.040 |
Why?
| | Neural Conduction | 1 | 2017 | 79 | 0.040 |
Why?
| | Plant Extracts | 1 | 1999 | 153 | 0.040 |
Why?
| | Brain Mapping | 1 | 2000 | 521 | 0.040 |
Why?
| | Liver Transplantation | 1 | 2004 | 830 | 0.040 |
Why?
| | Colon | 1 | 1999 | 234 | 0.040 |
Why?
| | Atrophy | 1 | 2017 | 152 | 0.040 |
Why?
| | Metagenomics | 1 | 2017 | 131 | 0.030 |
Why?
| | Hospitals, Pediatric | 1 | 2020 | 478 | 0.030 |
Why?
| | CA3 Region, Hippocampal | 1 | 2016 | 5 | 0.030 |
Why?
| | Complement Pathway, Classical | 1 | 2016 | 19 | 0.030 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2002 | 1147 | 0.030 |
Why?
| | Spatial Memory | 1 | 2016 | 17 | 0.030 |
Why?
| | Cell Culture Techniques | 1 | 2018 | 344 | 0.030 |
Why?
| | Immunity, Cellular | 1 | 1998 | 262 | 0.030 |
Why?
| | Proteins | 1 | 2002 | 920 | 0.030 |
Why?
| | Meat Products | 1 | 1995 | 25 | 0.030 |
Why?
| | Sensitivity and Specificity | 1 | 2000 | 1718 | 0.030 |
Why?
| | Blotting, Southern | 1 | 1995 | 66 | 0.030 |
Why?
| | Food Handling | 1 | 1995 | 48 | 0.030 |
Why?
| | Young Adult | 2 | 2022 | 10470 | 0.030 |
Why?
| | Phenylketonurias | 1 | 1995 | 11 | 0.030 |
Why?
| | Patient Reported Outcome Measures | 1 | 2017 | 250 | 0.030 |
Why?
| | Microscopy, Electron | 1 | 1995 | 409 | 0.030 |
Why?
| | Ammonium Chloride | 1 | 1994 | 4 | 0.030 |
Why?
| | Chymotrypsin | 1 | 1994 | 20 | 0.030 |
Why?
| | Cognition Disorders | 2 | 2009 | 475 | 0.030 |
Why?
| | Necrosis | 2 | 1998 | 210 | 0.030 |
Why?
| | Endothelial Cells | 1 | 2019 | 695 | 0.030 |
Why?
| | Complement Activation | 1 | 2016 | 343 | 0.030 |
Why?
| | Base Sequence | 2 | 1995 | 2114 | 0.030 |
Why?
| | Neuropsychological Tests | 2 | 2008 | 919 | 0.030 |
Why?
| | Antibody Affinity | 1 | 1993 | 52 | 0.030 |
Why?
| | Cell Survival | 2 | 2005 | 1024 | 0.030 |
Why?
| | DNA Damage | 1 | 1995 | 357 | 0.030 |
Why?
| | Co-Repressor Proteins | 1 | 2013 | 13 | 0.030 |
Why?
| | Cattle | 1 | 1995 | 935 | 0.030 |
Why?
| | Thymidine Kinase | 2 | 1989 | 14 | 0.030 |
Why?
| | Syndrome | 2 | 2007 | 339 | 0.030 |
Why?
| | Occupational Exposure | 1 | 1995 | 262 | 0.030 |
Why?
| | Anti-HIV Agents | 1 | 1999 | 669 | 0.030 |
Why?
| | Trigeminal Ganglion | 2 | 1989 | 21 | 0.030 |
Why?
| | bcl-X Protein | 1 | 2012 | 39 | 0.030 |
Why?
| | Hemagglutination | 1 | 1991 | 7 | 0.030 |
Why?
| | Triterpenes | 1 | 2012 | 17 | 0.030 |
Why?
| | Binding Sites, Antibody | 1 | 1991 | 36 | 0.030 |
Why?
| | Cohort Studies | 1 | 2022 | 4944 | 0.030 |
Why?
| | Immunoglobulin Isotypes | 1 | 1991 | 32 | 0.020 |
Why?
| | Proteolysis | 1 | 2012 | 145 | 0.020 |
Why?
| | Primary Cell Culture | 1 | 2012 | 149 | 0.020 |
Why?
| | Antigens, Differentiation, T-Lymphocyte | 1 | 1991 | 85 | 0.020 |
Why?
| | Molecular Chaperones | 1 | 2013 | 157 | 0.020 |
Why?
| | CD8 Antigens | 1 | 1991 | 69 | 0.020 |
Why?
| | Clone Cells | 1 | 1991 | 248 | 0.020 |
Why?
| | Diuresis | 1 | 1991 | 8 | 0.020 |
Why?
| | CD4 Antigens | 1 | 1991 | 124 | 0.020 |
Why?
| | Reproducibility of Results | 1 | 1998 | 2800 | 0.020 |
Why?
| | Rats, Inbred Strains | 1 | 1991 | 376 | 0.020 |
Why?
| | Chromosome Mapping | 1 | 1991 | 489 | 0.020 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2012 | 332 | 0.020 |
Why?
| | STAT3 Transcription Factor | 1 | 2012 | 174 | 0.020 |
Why?
| | Antibody Formation | 1 | 1991 | 273 | 0.020 |
Why?
| | Calcium Channels | 1 | 1991 | 146 | 0.020 |
Why?
| | Nerve Fibers, Unmyelinated | 1 | 2009 | 9 | 0.020 |
Why?
| | Excitatory Amino Acid Transporter 2 | 1 | 2009 | 13 | 0.020 |
Why?
| | Prospective Studies | 2 | 1998 | 6264 | 0.020 |
Why?
| | CD11 Antigens | 1 | 2009 | 31 | 0.020 |
Why?
| | Trigeminal Nerve | 1 | 1989 | 28 | 0.020 |
Why?
| | Incidence | 1 | 1995 | 2335 | 0.020 |
Why?
| | Paresis | 1 | 2009 | 28 | 0.020 |
Why?
| | Esophagitis | 1 | 1989 | 65 | 0.020 |
Why?
| | Immunoglobulins | 1 | 2009 | 147 | 0.020 |
Why?
| | Precipitin Tests | 1 | 1988 | 90 | 0.020 |
Why?
| | Hemagglutination Inhibition Tests | 1 | 1988 | 37 | 0.020 |
Why?
| | Optic Neuritis | 1 | 2009 | 37 | 0.020 |
Why?
| | Dendrites | 1 | 2009 | 85 | 0.020 |
Why?
| | Radioimmunoassay | 1 | 1988 | 163 | 0.020 |
Why?
| | Cross Reactions | 1 | 1988 | 117 | 0.020 |
Why?
| | alpha 1-Antitrypsin Deficiency | 1 | 2009 | 78 | 0.020 |
Why?
| | Muscles | 1 | 1989 | 326 | 0.020 |
Why?
| | Genetic Variation | 1 | 1993 | 877 | 0.020 |
Why?
| | Mental Status Schedule | 1 | 2008 | 34 | 0.020 |
Why?
| | Isaacs Syndrome | 1 | 2007 | 4 | 0.020 |
Why?
| | Skin Diseases | 1 | 2009 | 124 | 0.020 |
Why?
| | Glomerular Filtration Rate | 1 | 1991 | 605 | 0.020 |
Why?
| | Lymphocyte Activation | 1 | 1991 | 1057 | 0.020 |
Why?
| | Neurologic Examination | 1 | 2008 | 116 | 0.020 |
Why?
| | Peripheral Nerves | 1 | 2007 | 65 | 0.020 |
Why?
| | Gene Expression | 1 | 2012 | 1435 | 0.020 |
Why?
| | Oxidants | 1 | 2007 | 112 | 0.020 |
Why?
| | Genes, Regulator | 1 | 1986 | 33 | 0.020 |
Why?
| | Prednisone | 1 | 2007 | 232 | 0.020 |
Why?
| | Protein Kinase Inhibitors | 1 | 2012 | 790 | 0.020 |
Why?
| | Forelimb | 1 | 1986 | 25 | 0.020 |
Why?
| | Superoxides | 1 | 2007 | 215 | 0.020 |
Why?
| | Surveys and Questionnaires | 1 | 1998 | 4665 | 0.020 |
Why?
| | RNA, Double-Stranded | 1 | 1986 | 44 | 0.020 |
Why?
| | Synapses | 1 | 2009 | 336 | 0.020 |
Why?
| | Sciatic Nerve | 1 | 1986 | 56 | 0.020 |
Why?
| | Graft Rejection | 1 | 2009 | 533 | 0.020 |
Why?
| | Hindlimb | 1 | 1986 | 125 | 0.020 |
Why?
| | Infant, Newborn | 1 | 2016 | 5077 | 0.020 |
Why?
| | Bcl-2-Like Protein 11 | 1 | 2005 | 38 | 0.020 |
Why?
| | Genes, Dominant | 1 | 2005 | 93 | 0.020 |
Why?
| | Politics | 1 | 1986 | 79 | 0.020 |
Why?
| | rho GTP-Binding Proteins | 1 | 2005 | 62 | 0.020 |
Why?
| | Integrins | 1 | 2005 | 79 | 0.020 |
Why?
| | Blood Pressure | 1 | 1991 | 1537 | 0.010 |
Why?
| | Pathology | 1 | 1984 | 21 | 0.010 |
Why?
| | Vesicular stomatitis Indiana virus | 1 | 2004 | 13 | 0.010 |
Why?
| | Muromegalovirus | 1 | 2004 | 13 | 0.010 |
Why?
| | Lymphocytic choriomeningitis virus | 1 | 2004 | 20 | 0.010 |
Why?
| | Massachusetts | 1 | 1984 | 137 | 0.010 |
Why?
| | Cell Adhesion | 1 | 2005 | 433 | 0.010 |
Why?
| | Immunotherapy | 1 | 2007 | 479 | 0.010 |
Why?
| | Aphasia | 1 | 2003 | 19 | 0.010 |
Why?
| | Antioxidants | 1 | 2007 | 533 | 0.010 |
Why?
| | Focal Adhesion Kinase 1 | 1 | 2003 | 27 | 0.010 |
Why?
| | Schools, Medical | 1 | 1984 | 123 | 0.010 |
Why?
| | Focal Adhesion Protein-Tyrosine Kinases | 1 | 2003 | 27 | 0.010 |
Why?
| | Temporal Lobe | 1 | 2003 | 80 | 0.010 |
Why?
| | Toll-Like Receptors | 1 | 2004 | 166 | 0.010 |
Why?
| | Patella | 1 | 1983 | 25 | 0.010 |
Why?
| | Diffusion Magnetic Resonance Imaging | 1 | 2003 | 85 | 0.010 |
Why?
| | Intestines | 1 | 1986 | 324 | 0.010 |
Why?
| | Lethal Dose 50 | 1 | 2002 | 12 | 0.010 |
Why?
| | Hydrolysis | 1 | 2003 | 179 | 0.010 |
Why?
| | Epidermal Growth Factor | 1 | 2003 | 161 | 0.010 |
Why?
| | Fluorescence | 1 | 2003 | 154 | 0.010 |
Why?
| | Papillomaviridae | 1 | 2003 | 100 | 0.010 |
Why?
| | Hypertrophy | 1 | 1983 | 110 | 0.010 |
Why?
| | Injections, Intramuscular | 1 | 2002 | 118 | 0.010 |
Why?
| | Headache | 1 | 2003 | 131 | 0.010 |
Why?
| | NF-KappaB Inhibitor alpha | 1 | 2002 | 52 | 0.010 |
Why?
| | DNA Fingerprinting | 1 | 2002 | 27 | 0.010 |
Why?
| | Electroencephalography | 1 | 2003 | 365 | 0.010 |
Why?
| | Oxidative Stress | 1 | 2007 | 1093 | 0.010 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2003 | 930 | 0.010 |
Why?
| | Liver Diseases | 1 | 2003 | 263 | 0.010 |
Why?
| | Cloning, Molecular | 1 | 2002 | 523 | 0.010 |
Why?
| | Tumor Cells, Cultured | 1 | 2002 | 850 | 0.010 |
Why?
| | Multienzyme Complexes | 1 | 2000 | 64 | 0.010 |
Why?
| | Cysteine Endopeptidases | 1 | 2000 | 61 | 0.010 |
Why?
| | Protein-Tyrosine Kinases | 1 | 2003 | 396 | 0.010 |
Why?
| | Proteasome Endopeptidase Complex | 1 | 2000 | 136 | 0.010 |
Why?
| | Drug Resistance, Microbial | 2 | 1989 | 66 | 0.010 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2004 | 693 | 0.010 |
Why?
| | Ion Transport | 1 | 1999 | 55 | 0.010 |
Why?
| | Gene Deletion | 1 | 2000 | 355 | 0.010 |
Why?
| | Kidney Failure, Chronic | 1 | 2003 | 490 | 0.010 |
Why?
| | CD4-Positive T-Lymphocytes | 1 | 2004 | 965 | 0.010 |
Why?
| | HIV Seropositivity | 1 | 1998 | 110 | 0.010 |
Why?
| | Carcinoma, Squamous Cell | 1 | 2002 | 577 | 0.010 |
Why?
| | Diet, Protein-Restricted | 1 | 1995 | 10 | 0.010 |
Why?
| | Phenylalanine | 1 | 1995 | 58 | 0.010 |
Why?
| | DNA-Binding Proteins | 1 | 2002 | 1316 | 0.010 |
Why?
| | Immunoblotting | 1 | 1994 | 281 | 0.010 |
Why?
| | Lymphocyte Depletion | 1 | 1993 | 116 | 0.010 |
Why?
| | Lymphocytes | 1 | 1994 | 344 | 0.010 |
Why?
| | Amino Acids | 1 | 1995 | 454 | 0.010 |
Why?
| | Breast Neoplasms | 1 | 2002 | 1872 | 0.010 |
Why?
| | Viral Plaque Assay | 1 | 1989 | 24 | 0.010 |
Why?
| | Restriction Mapping | 1 | 1989 | 77 | 0.010 |
Why?
| | Chromosome Deletion | 1 | 1989 | 95 | 0.010 |
Why?
| | Lung Neoplasms | 1 | 2002 | 2207 | 0.010 |
Why?
| | Nucleic Acid Hybridization | 1 | 1989 | 189 | 0.010 |
Why?
| | Genes | 1 | 1989 | 224 | 0.010 |
Why?
| | Eye | 1 | 1989 | 101 | 0.000 |
Why?
| | Codon | 1 | 1986 | 86 | 0.000 |
Why?
|
|
Tyler's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|